Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kent A Griffith

Showing results (71-80 of 174) with videos related to

Pageof 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2022
Incidence, Nature, and Consequences of Oncologists' Experiences With Sexual HarassmentIshwaria M Subbiah, Merry Jennifer Markham, Stephanie L Graff, et al.
The Breast Journal|August 27, 2016
Differences between Breast Conservation-Eligible Patients and Unilateral Mastectomy Patients in Choosing Contralateral Prophylactic MastectomiesMichael S Sabel, Casey T Kraft, Kent A Griffith, et al.
JNCI Cancer Spectrum|November 23, 2022
Frequency, barriers, outcomes, and consequences of reporting sexual harassment in clinical oncologyStephanie L Graff, Ishwaria M Subbiah, Merry Jennifer Markham, et al.
International Journal of Radiation Oncology, Biology, Physics|May 5, 2009
Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiationReshma Jagsi, Merav A Ben-David, Jean M Moran, et al.
Breast Cancer Research and Treatment|September 28, 2005
RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breastCelina G Kleer, Kent A Griffith, Michael S Sabel, et al.
Cancer|June 28, 2007
Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary siteBryan J Schneider, Basil El-Rayes, Jeffery H Muler, et al.
The Breast Journal|June 27, 2007
Long-term results of conservative surgery and radiotherapy for ductal carcinoma in situ using lung density correction: the University of Michigan experienceMerav A Ben-David, David E Sturtz, Kent A Griffith, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Accelerated partial breast irradiation: what is dosimetric effect of advanced technology approaches?Jean M Moran, Merav A Ben-David, Robin B Marsh, et al.
Journal of Oncology Practice|March 5, 2015
Wide Variation in the Diffusion of a New Technology: Practice-Based Trends in Intensity-Modulated Radiation Therapy (IMRT) Use in the State of Michigan, With Implications for IMRT Use NationallyDean A Shumway, Kent A Griffith, Lori J Pierce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancerReshma Jagsi, Kent A Griffith, Allison W Kurian, et al.
Pageof 18

Showing results (71-80 of 174) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2022
Incidence, Nature, and Consequences of Oncologists' Experiences With Sexual HarassmentIshwaria M Subbiah, Merry Jennifer Markham, Stephanie L Graff, et al.
The Breast Journal|August 27, 2016
Differences between Breast Conservation-Eligible Patients and Unilateral Mastectomy Patients in Choosing Contralateral Prophylactic MastectomiesMichael S Sabel, Casey T Kraft, Kent A Griffith, et al.
JNCI Cancer Spectrum|November 23, 2022
Frequency, barriers, outcomes, and consequences of reporting sexual harassment in clinical oncologyStephanie L Graff, Ishwaria M Subbiah, Merry Jennifer Markham, et al.
International Journal of Radiation Oncology, Biology, Physics|May 5, 2009
Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiationReshma Jagsi, Merav A Ben-David, Jean M Moran, et al.
Breast Cancer Research and Treatment|September 28, 2005
RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breastCelina G Kleer, Kent A Griffith, Michael S Sabel, et al.
Cancer|June 28, 2007
Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary siteBryan J Schneider, Basil El-Rayes, Jeffery H Muler, et al.
The Breast Journal|June 27, 2007
Long-term results of conservative surgery and radiotherapy for ductal carcinoma in situ using lung density correction: the University of Michigan experienceMerav A Ben-David, David E Sturtz, Kent A Griffith, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Accelerated partial breast irradiation: what is dosimetric effect of advanced technology approaches?Jean M Moran, Merav A Ben-David, Robin B Marsh, et al.
Journal of Oncology Practice|March 5, 2015
Wide Variation in the Diffusion of a New Technology: Practice-Based Trends in Intensity-Modulated Radiation Therapy (IMRT) Use in the State of Michigan, With Implications for IMRT Use NationallyDean A Shumway, Kent A Griffith, Lori J Pierce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancerReshma Jagsi, Kent A Griffith, Allison W Kurian, et al.
Pageof 18